Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antiangiogenic drug to treat cancer, arthritis and retinopathy

Antiangiogenic drug to treat cancer, arthritis and retinopathy

US Patent 6632961 · Granted Oct 14, 2003

Estimated economic value: $123,929,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2022
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2021
Bromodomain inhibitors2020
Nanocarriers having surface conjugated peptides and uses thereof for sustained l2020
Bromodomain inhibitors2018
Bromodomain inhibitors2018
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for 2018
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadib2018
Bromodomain inhibitors2018
Isoindolone derivatives2017
Primary carboxamides as BTK inhibitors2017
Pyridinone and pyridazinone derivatives2017